Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... and C - 4 doses will be given prior to transplant to promote engraftment. Other Name: thymoglobulin Drug: G-CSF All patients will also receive G-CSF post-transplant to foster engraftment. Other Names: Granulocyte colony-stimulating factor ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  2. Transplantation Basics

    ... globulin (ATG) have some benefit in facilitating engraftment of donor cells and in reducing the incidence of GVHD. However, ... they have generally not been sufficient to secure engraftment of donor cells. Even for a good candidate for stem cell ...

    Interview last updated 04/05/2013 - 2:33pm.

  3. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... and C - 4 doses will be given prior to transplant to promote engraftment. Other Name: thymoglobulin Drug: G-CSF All patients will also receive G-CSF post-transplant to foster engraftment. Other Names: Granulocyte colony-stimulating factor ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  4. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... studies. Stop MMF at Day +30 or 7 days after engraftment, whichever day is later, if no acute graft versus host disease (GVHD). (Definition of engraftment is 1st day of 3 consecutive days of absolute neutrophil count [ANC) ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  5. Allo HSCT Using RIC for Hematological Diseases

    ... studies. MMF will stop at day +30 or 7 days after engraftment, whichever day is later, if no acute GVHD. (Definition of engraftment is 1st day of 3 consecutive days of absolute neutrophil count [ANC) ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  6. Busulfan and Cyclophosphamide Followed By ALLO BMT

    ... mg/kg 3 times per day (< 40 kg) for up to 30 days unless no engraftment. Other Name: MMF Biological: Allogeneic hematopoietic ...

    Clinical Trial last updated 04/29/2016 - 1:23pm.

  7. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... between days +6 and +30. Stop MMF at day +30 or 7 days after engraftment, whichever day is later, if no acute GVHD. Intervention: ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.